Multiple-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in HIV-Infected Patients

By Morse G.D.  

Clinical Drug Investigation, Vol. 23, Iss. 5, 2003-01 ,pp. : 323-328

Adis International

Access to resources Recommend Favorite

Steady-state Pharmacokinetics of Clozapine in Refractory Schizophrenic Saudi Arabian Patients

By Hussein R.   Gad A.   Raines D.A.   Chaleby K.   Al-Rawithi S.   El-Yazigi A.  

Pharmacy and Pharmacology Communications, Vol. 5, Iss. 7, 1999-07 ,pp. : 473-478

Pharmaceutical Press

Access to resources Recommend Favorite

Population Pharmacokinetics of Delavirdine and N -Delavirdine in HIV-Infected Individuals

By Patrick F. Smith   Robert DiCenzo  

Clinical Pharmacokinetics, Vol. 44, Iss. 1, 2005-01 ,pp. : 99-109

Adis International

Access to resources Recommend Favorite

Delavirdine: A Review of its Use in HIV Infection

By Scott L.J.   Perry C.M.  

Drugs, Vol. 60, Iss. 6, 2000-12 ,pp. : 1411-1444

Adis International

Access to resources Recommend Favorite

Tenofovir comedication does not impair the steady-state pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected adults

By Hentig Nils   Dauer Brenda   Haberl Annette   Klauke Stefan   Lutz Thomas   Staszewski Schlomo   Harder Sebastian  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 10, 2007-10 ,pp. : 935-940

Springer Publishing Company

Access to resources Recommend Favorite